Axsome Therapeutics, Inc (AXSM) Dividend History

Company News

• 2 Soaring Stocks Wth More Upside Potential

  The article discusses two biotech companies, Summit Therapeutics and Axsome Therapeutics, that have seen significant stock price gains in recent years. Despite their recent performance, the author believes there is still potential upside for investors in these companies.

  The Motley Fool

  Featured Companies: SMMT
• Investor Alert: Class Action Lawsuits Against General Motors, DocGo, Estée Lauder, and Axsome Therapeutics Survive Motions to Dismiss — Johnson Fistel, PLLP Encourages Shareholders to Contact the Firm

  Johnson Fistel, PLLP is investigating potential violations of federal and state laws by certain officers of General Motors, DocGo, Estée Lauder, and Axsome Therapeutics. The securities class action lawsuits against these companies have survived motions to dismiss.

  GlobeNewswire Inc.

  Featured Companies: DCGO EL GM
• Axsome Therapeutics to Participate in Upcoming Investor Conferences

  Axsome Therapeutics announced its participation in upcoming investor conferences and provided updates on its neuroscience programs and SUNOSI® patent litigation settlement.

  GlobeNewswire Inc.
• Why Is Teva Stock Trading Higher On Tuesday?

  Teva Pharmaceutical and Biolojic Design announced that Teva initiated IND-enabling studies with BD9, a dual-specific multibody targeting both TSLP and IL-13, which can potentially improve outcomes for patients with conditions such as atopic dermatitis and asthma.

  Benzinga

  Featured Companies: ALVO JNJ
• Is Axsome Therapeutics Stock Worth the Risk? A Comprehensive Analysis

  The Motley Fool is a financial services company founded in 1993, dedicated to making the world smarter, happier, and richer. It reaches millions of people through its premium investing solutions, free guidance, market analysis, personal finance education, top-rated podcasts, and non-profit foundation.

  The Motley Fool